Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplification

• Published in: Modern pathology Vol. 31; no. 12; pp. 1816 - 1833
• Main Authors: de Boer, Mirthe, Verschuur-Maes, Anoek H. J., Buerger, Horst, Moelans, Cathy B, Steenkamer, Maryvonne, Savola, Suvi, van Diest, Paul J.
• Format: Journal Article
• Language: English
• Published: New York Nature Publishing Group US 01.12.2018; Elsevier Limited
• Subjects: 45/77; 631/67/1347; 692/420/755; Adult; Aged; Aged, 80 and over; Breakpoints; Breast cancer; Breast carcinoma; Breast Neoplasms - genetics; Breast Neoplasms - pathology; Carcinogenesis; Cell Transformation, Neoplastic - genetics; Chromosome 16; Chromosomes, Human, Pair 16 - genetics; Copy number; Epithelial Cells - pathology; Female; Gene Dosage; Health risk assessment; Humans; Hyperplasia; Invasiveness; Laboratory Medicine; Medicine; Medicine & Public Health; Middle Aged; Multiplex Polymerase Chain Reaction; Pathology; Precancerous Conditions - genetics; Precancerous Conditions - pathology; Tumor suppressor genes; Tumors
• DOI: 10.1038/s41379-018-0099-2
• ISSN: 0893-3952

Columnar cell lesions have been proposed as precursor lesions of low-grade breast cancer. The molecular characteristic of low-grade breast neoplasia is whole-arm loss of chromosome 16q. Copy number changes of 6 genes on 16p and 20 genes on 16q were analysed by multiplex ligation-dependent probe amplification in 165 lesions of 103 patients. Twenty-three columnar cell lesions and 19 atypical ducal hyperplasia lesions arising in columnar cell lesions were included, as well as cases of usual ductal hyperplasia, blunt duct adenosis, ductal carcinoma in situ, lobular neoplasia and invasive carcinoma. Usual ductal hyperplasia and blunt duct adenosis lacked whole-arm losses of 16q. In contrast, columnar cell lesions without atypia, columnar cell lesions with atypia, atypical ductal hyperplasia, low-grade ductal carcinoma in situ and low-grade invasive carcinomas increasingly harboured whole-arm losses of 16q (17%, 27%, 47% and 57%, respectively). However, no recurrent losses in specific genes could be identified. In several patients, columnar cell lesions and atypical ductal hyperplasia harboured similar losses as related ductal carcinoma in situ or invasive carcinomas within the same breast. There were indications for 16q breakpoints near the centromere. Whole-arm gains on 16p were relatively scarce and there was no relation between whole-arm gains of 16p and progression of lesions of the low-grade breast neoplasia family. In conclusion, columnar cell lesions (with and without atypia) often harbour whole-arm losses of 16q, which underlines their role as precursors in low-grade breast carcinogenesis, in contrast with usual ductal hyperplasia and blunt duct adenosis. However, no recurrent losses in specific genes could be identified, pointing to minor events in multiple tumour suppressor genes rather than major events in a single 16q gene contributing to low-grade breast carcinogenesis.